The Trump administration's USPTO silence tells us all we need to know about its patent priorities
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Editor-in-chief
@IAM_Alerts Saturday Opinion: top in-house professionals from Australia say country is systematically under-investing in IP… https://t.co/UaqE1uV8TU Read more
@IAM_Alerts The CAFC tees up a patent fight over Moderna's multi-billion-dollar covid-19 revenues. Arbutus and Roivant shares s… https://t.co/i87DzyZpkP Read more
@IAM_Alerts Huawei knocks out licensing company's Chinese patents as the pair continue global SEP dispute… https://t.co/1b8yaR9g28 Read more
@IAM_Alerts Federal Circuit confirms Biogen’s multi-billion dollar Tecfidera patent disaster: https://t.co/9UjLQAuUsv https://t.co/8Qw2wZPm5L Read more